| Metric | შპს მაქსფარმა | შპს ანშენ ფარმა | შპს Linema Pharm |
|---|---|---|---|
| Growth | |||
| Revenue | ₾1.8m | ₾0 | ₾3.9m |
| Revenue growth | — | — | — |
| Profitability | |||
| EBITDA | -₾67k | ₾0 | ₾1.6m |
| EBITDA margin | -3.7% | — | 40.5% |
| Net profit | -₾67k | ₾0 | ₾1.5m |
| Net margin | -3.7% | — | 38.9% |
| Balance sheet | |||
| Total assets | ₾202k | ₾1.3m | ₾6.3m |
| Total equity | -₾26k | ₾869k | ₾5.6m |
| ROE | — | 0.0% | 27.1% |